Atomoxetine augmentation in a case of treatment resistant panic disorder with multiple augments failure: A case report

0Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.

Cite

CITATION STYLE

APA

Ram, D., Patil, S., Gowdappa, B., & Rajalakshmi, I. (2015). Atomoxetine augmentation in a case of treatment resistant panic disorder with multiple augments failure: A case report. Clinical Psychopharmacology and Neuroscience, 13(3), 321–323. https://doi.org/10.9758/cpn.2015.13.3.321

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free